Oric Pharmaceuticals (ORIC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist

9.850
+0.240+2.50%

Trading May 8 10:58 ET

664.11MMarket Cap-5472P/E (TTM)

Intraday

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We're Not Very Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a ne
Simply Wall St08:47 ET
Buy Rating on Oric Pharmaceuticals Amidst Strong Financials and Promising Clinical Pipeline
TipRanks06:27 ET
Analysts Offer Insights on Healthcare Companies: Ardelyx (ARDX), Oric Pharmaceuticals (ORIC) and Cellectis SA (CLLS)
TipRanks00:50 ET
Oric Pharmaceuticals Is Maintained at Buy by Citigroup
Oric Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones13:47 ET
Express News | Citigroup Maintains Buy on ORIC Pharmaceuticals, Lowers Price Target to $14
Benzinga13:37 ET
ORIC Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/07/2024 42.99% Citigroup $15 → $14 Maintains Buy 03/27/2024 83.85% JP Morgan $19 → $18 Maintains Overwe
Benzinga13:36 ET

Comments

SlowndEasyTrades

Mar 21 05:06

$Oric Pharmaceuticals(ORIC.US)$
too much in red long time out from this non mover !

Moomoo AI

Oct 12, 2023 03:38

Despite a promising cash runway, ORIC Pharmaceuticals' cash burn relative to its market cap may pose future risks. If new shares are issued to fund operations, shareholders could face costly dilution. The cash burn is not a major concern currently, but shareholders need to pay attention.